State Street SPDR標普製藥ETF XPH 深 滬
等待開盤 05-15 09:30:00 美东时间
58.89
-0.210
-0.36%
華盛通- 最 高59.20
- 今 開59.20
- 成交量 1.33万股
- 最 低 58.62
- 昨 收 59.10
- 總市值 3.62亿
- 52周最高 60.73
- 市盈率 靜 --
- 換手率 0.22%
- 52周最低 39.6375
- 委 比 -11.11%
- 總股本 615.03万
- 歷史最高 60.73
- 量 比 0.87
- 振 幅 0.98%
- 歷史最低 27.2075
- 每 手 1
- 風險率 6.36%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Why Is Organon Stock Skyrocketing Monday?
Sun Pharma to acquire Organon in an all-cash deal valued at $11.75 billion. OGN shares rise on the acquisition news.
04-27 17:57
Why Is Amneal Pharmaceuticals Stock Gaining Today?
Amneal Pharmaceuticals rises premarket after $1.1B Kashiv BioSciences deal to expand biosimilars platform and tap $300B biologics opportunity, while raising FY26 outlook.
04-22 19:15
Axsome Stock Climbs On Schizophrenia Drug Deal With Takeda
Axsome gains after securing global rights to balipodect from Takeda, advancing schizophrenia pipeline amid bullish analyst targets.
04-02 01:36
Prestige Bets $1 Billion On World's Most Iconic Nasal Strip
Prestige Consumer Healthcare acquires Breathe Right brand for $1.045 billion. Deal expands OTC portfolio into sleep & breathing categories.
03-20 19:56
Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks'
Trump's "Great Healthcare Plan" targets PBM kickbacks to cut costs. Experts confirm these fees act as an industry "vig" driving up prices.
01-16 15:30
Why Health Care ETFs Aren't Panicking Over Big Pharma's Price Cuts
Healthcare ETFs stay resilient as Big Pharma agrees to Medicaid drug price cuts. Here's what is cushioning ETFs despite pricing pressure.
2025-12-20 04:17
Will valuations see a floor? – Morgan Stanley’s Mike Wilson
If nominal GDP and earnings growth accelerate due to higher inflation, stocks’ valuation may see a support ahead, according to Michael J. Wilson, chief U.S. equity strategist and chief investment offi...
2025-10-07 00:51
Pharma stocks at 15-year valuation lows may offer value – BMO’s Evan Seigerman
Drug pricing policy clarity from the Trump administration could signal a turning point for pharmaceutical stocks (PPH), (PJP), (NYSEARCA:XPH), which have been among the worst performers this year with...
2025-10-02 02:51
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk
The U.S. pharmaceutical industry is at the center of a policy maelstrom.
2025-09-30 00:06
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms
President Donald Trump's proposed 100% tariffs on foreign pharmaceuticals will ultimately be paid by American patients and insurers, not foreign drug companies, according to economist Justin Wolfers.
2025-09-29 15:20
